Regulatory Affairs Professionals Society: This Week at FDA: WH reviewing candidates for FDA boss, a pause on posting CRLs, and more

The Reagan-Udall Foundation for the FDA and FDA are hosting a hybrid meeting on 5 August to discuss selection criteria and prioritization when considering repurposing drugs for new indications or new populations.